Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Lanzetta
Observed name:
I. Lanzetta
Institutions:
University of Pavia,
Intensive Care Foundation,
Foundation Center,
Policlinico San Matteo Fondazione,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
University of Pavia,
Intensive Care Foundation,
Foundation Center,
Policlinico San Matteo Fondazione,
Istituti di Ricovero e Cura a Carattere Scientifico
OpenAlex ID:
A5116446914
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index
2025
·
Mara Persano
, Margherita Rimini
, et al.
·
Liver International
·
11
PDF
Novel androgen receptor inhibitors in prostate cancer: What do we know so far?
2025
·
Francesca Rifaldi
, Anna Tortorella
, et al.
·
Critical Reviews in Oncology/Hematology
·
4
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations
2025
·
Silvio Sporeni
, Francesca Rifaldi
, et al.
·
Radiology and Oncology
·
2
Prognostic value of hormone receptor expression in patients with HR+/HER2− advanced BC treated with first-line ET+CDK4/6i: results from the multicentre observational, real-world PALMARES-2 study
2026
·
Francesca Ligorio
, Leonardo Provenzano
, et al.
·
EClinicalMedicine
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study
2026
·
H. Vandeputte
, A. Casadei-Gardini
, et al.
·
ESMO Gastrointestinal Oncology
PDF
Thyroid toxicity in lung cancer patients treated with immune-checkpoint inhibitors: a single-center retrospective analysis
2026
·
Niccolò Leandro Alessio
, Gabriele Ferrari
, et al.
·
Frontiers in Immunology
PDF
220eP Thyroid toxicity in lung cancer patients treated with immune-checkpoint inhibitors: A single-center retrospective analysis
2025
·
N.L. Alessio
, G. Ferrari
, et al.
·
Immuno-Oncology Technology
P1.11.54 Lack of Durable Response to ICI Therapy in Advanced NSCLC: The Role of Circulating Lazy T Cells
2025
·
A. Palladini
, P.L.S. Michel
, et al.
·
Journal of Thoracic Oncology
Rechallenge with Chemotherapy Versus Best Supportive Care for the Treatment of Malignant Pleural Mesothelioma in Advanced Lines: A Single-Institution Comparative Case Analysis
2025
·
Gabriele Ferrari
, Giulia Maria Stella
, et al.
·
Preprints.org
PDF
355P: Effect of immunotherapy on the peripheral immunoscore of patients affected by non-small cell lung cancer long responders or fast progressors
2025
·
N.L. Alessio
, P. Michel
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type